Recombinant Human RELA Protein，His

RELA, a pivotal component of the NF-κB signaling pathway, plays a critical role in regulating immune responses, inflammation, and cell survival. The RELA protein, or p65, serves as a transcription factor that influences the expression of various genes involved in these biological processes. Dysregulation of RELA has been implicated in various diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. Researchers have increasingly focused on the study of recombinant RELA proteins to elucidate their structure-function relationships and their interactions with other molecular partners. The development of recombinant RELA offers valuable insights into the functional mechanisms of this protein and opens avenues for potential therapeutic interventions targeting NF-κB signaling. By producing RELA in a controlled laboratory setting, scientists are able to perform detailed functional assays, characterizing its activity, understanding its role in cellular signaling, and exploring ways to modulate its activity for therapeutic benefit. Furthermore, studying RELA in a recombinant form allows for the identification of post-translational modifications and interacting partners, which are crucial for its activation and function. Consequently, ongoing research into recombinant RELA not only enhances the understanding of its biological significance but also contributes to the discovery of novel strategies for drug development aimed at diseases associated with aberrant NF-κB signaling.